Induction of immune tolerance in asthmatic mice by vaccination with DNA encoding an allergen-cytotoxic T lymphocyte-associated antigen 4 combination

Clinical and Vaccine Immunology

Volumn 18, Issue 5, 2011, Pages 807-814

  Zhang, Fang ^a   Huang, Gang ^b   Hu, Bo ^a   Song, Yong ^a   Shi, Yi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA VACCINE; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3;

AIRFLOW; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; DNA IMMUNIZATION; EOSINOPHIL; EOSINOPHIL COUNT; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; TH2 CELL;

ALLERGENS; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES, REGULATORY; VACCINATION; VACCINES, DNA;

EID: 79955719651     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00434-10     Document Type: Article

References (26)

1. + T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells. Eur. J. Haematol. 81:209-217.
2. Ahrens, B., et al. 2009. BCG priming of dendritic cells enhances T regulatory and Th1 function and suppresses allergen-induced Th2 function in vitro and in vivo. Int. Arch. Allergy Immunol. 150:210-220.
3. Akdis, M., and C. A. Akdis. 2007. Mechanisms of allergen-specific immunotherapy. J. Allergy Clin. Immunol. 119:780-791.
4. + regulatory thymocytes because of their responsiveness to different cytokines. Blood 103:3117-3121.
5. Cusi, M. G., et al. 2004. Efficient delivery of DNA to dendritic cells mediated by influenza virosomes. Vaccine 22:735-739. (Pubitemid 38114904)
6. Deliyannis, G., J. S. Boyle, J. L. Brady, L. E. Brown, and A. M. Lew. 2000. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc. Natl. Acad. Sci. U. S. A. 97:6676-6680.
7. Gupta, N., et al. 2006. Identification and characterization of p63 (CKAP4/ERGIC-63/CLIMP-63), a surfactant protein A binding protein, on type II pneumocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L436-L446.
8. HuangFu, T., L. H. Lim, and K. Y. Chua. 2006. Efficacy evaluation of Derp1 DNA vaccine for allergic asthma in an experimental mouse model. Vaccine 24:4576-4581.
9. Jacobsen, L. 2001. Preventive aspects of immunotherapy: prevention for children at risk of developing asthma. Ann. Allergy Asthma Immunol. 87:43-46.
10. Jang, A. S., et al. 2004. Changes in the expression of NO synthase isoforms after ozone: the effects of allergen exposure. Respir. Res. 5:5.
11. Jutel, M., and C. A. Akdis. 2008. T-cell regulatory mechanisms in specific immunotherapy. Chem. Immunol. Allergy 94:158-177.
12. Knutson, K. L., and M. L. Disis. 2005. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol. Immunother. 54:721-728.
13. Lombardi, V., A. K. Singh, and O. Akbari. 2010. The role of costimulatory molecules in allergic disease and asthma. Int. Arch. Allergy Immunol. 151:179-189.
14. Maecker, H. T., et al. 2001. Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model. J. Immunol. 166:959-965. (Pubitemid 32060251)
15. + T cells is associated with the phenotypes of allergic asthma. Respirology 14:187-194.
16. Miwa, N., et al. 2005. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol. Hum. Reprod. 11:865-870.
17. Ohta, K., and N. Yamashita. 1999. Apoptosis of eosinophils and lymphocytes in allergic inflammation. J. Allergy Clin. Immunol. 104:14-21.
18. Rohrbach, F., et al. 2005. Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity. J. Immunol. 174:5481-5489. (Pubitemid 40593188)
19. Rolland, J. M., J. Douglass, and R. E. O'Hehir. 2000. Allergen immunotherapy: current and new therapeutic strategies. Expert Opin. Invest. Drugs 9:515-527.
20. Rolland, J. M., L. M. Gardner, and R. E. O'Hehir. 2009. Allergen-related approaches to immunotherapy. Pharmacol. Ther. 121:273-284.
21. Ruffini, P. A., et al. 2004. Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis. J. Leukoc. Biol. 76:77-85.
22. Ryanna, K., V. Stratigou, N. Safinia, and C. Hawrylowicz. 2009. Regulatory T cells in bronchial asthma. Allergy 64:335-347.
23. Sloots, A., et al. 2008. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma. Clin. Cancer Res. 14:6933-6943.
24. Underwood, S., M. Foster, D. Raeburn, S. Bottoms, and J. A. Karlsson. 1995. Time course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur. Respir. J. 8:2104-2113.
25. Verhagen, J., A. Taylor, C. A. Akdis, and M. Akdis. 2005. Advances in allergen-specific immunotherapy. Expert Opin. Biol. Ther. 5:537-544.
26. Zhang, F., et al. 2007. Enhanced efficacy of CTLA-4 fusion anti-caries DNA vaccines in gnotobiotic hamsters. Acta Pharmacol. Sin. 28:1236-1242.